Contact: John Sterling, 914-740-2196, email@example.com
GEN Reports on Growth of Mass Spectrometry Applications
New Rochelle, NY, May 15, 2012—Increasing numbers of scientists are incorporating mass spectrometry into their research projects now that mass spec systems have become more compact and affordable, Genetic Engineering & Biotechnology News (GEN). Investigators from a variety of disciplines are making the analysis of ever smaller samples of macromolecules faster, easier, more streamlined, less error-prone, and less paradoxical, according to the May 15 issue of GEN.
“A technology once confined to highly specialized laboratories has evolved to the point where it has found a home in a wider range of research and clinical centers,” says John Sterling, Editor-in-Chief, GEN.
For example, Hartmut Schlüter, Ph.D., professor at the University Medical Center Hamburg-Eppendorf, concentrates on mass spectrometric proteomics, i.e., detecting, purifying, and identifying unknown proteases for which the catalytic reaction is known. He relies on a special form of two-dimensional displacement chromatography using the Agilent Technologies HPLC-Chip, a miniaturized system designed to separate small amounts of peptides (down to femtomoles to attomoles) for analysis by mass spectrometry.
The GEN article also covers work taking place on mass spec at Marburg University, the University of North Carolina at Chapel Hill, Oklahoma State University, and the University of Texas at Arlington.
For a copy of the May 15 issue of GEN, please call (914) 740-2146, or email: firstname.lastname@example.org
Genetic Engineering & Biotechnology News, which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Translational Medicine.